Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches
, , , , , , , , , , , , , , , , , , y
14 sept 2018
Acerca de este artículo
Categoría del artículo: Research Article
Publicado en línea: 14 sept 2018
Páginas: 399 - 412
Recibido: 20 may 2018
Aceptado: 13 jul 2018
DOI: https://doi.org/10.2478/raon-2018-0036
Palabras clave
© 2018 Urska Ivanus, Tine Jerman, Alenka Repse Fokter, Iztok Takac, Veronika Kloboves Prevodnik, Mateja Marcec, Ursula Salobir Gajsek, Maja Pakiz, Jakob Koren, Simona Hutter Celik, Kristina Gornik Kramberger, Ulrika Klopcic, Rajko Kavalar, Simona Sramek Zatler, Biljana Grcar Kuzmanov, Mojca Florjancic, Natasa Nolde, Srdjan Novakovic, Mario Poljak, Maja Primic Zakelj, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Figure 1

Figure 2

Positive predictive value (PPV) of HPV test for CIN2+ and CIN3+ in women who had undergone colposcopy after a positive HPV test on self-collected sample and in women with concordant results of both HPV tests_ Results are stratified by the level of protection due to previous screening
Number of women with | PPV | |||||
---|---|---|---|---|---|---|
all | colposcopy | CIN2+ | CIN3+ | CIN2+ | CIN3+ | |
all women | 430 | 333 | 40 | 32 | 12.0% | 9.6 |
women with medium protection | 279 | 223 | 18 | 12 | 8.1% | 5.4 |
women with no/low protection | 151 | 110 | 22 | 20 | 20.0% | 18.2 |
Results of HPV tests were concordant, if HPV test on self-collected sample as well as sample taken by a practitioner were positive. | ||||||
all women | na Results not available (na), since only women with colposcopy had a sample taken by a practitioner. | 146 | 34 | 29 | 23.3% | 19.9 |
women with medium protection | na | 97 | 14 | 10 | 14.4% | 10.3 |
women with no/low protection | na | 49 | 20 | 19 | 40.8% | 38.8 |
The main results by their predictors_ Intention-to-screen response rates, the mean age of responders and histological outcomes are presented as absolute numbers, proportions (per 100 or 1_000) and 95% confidence intervals (CI) by the study group, the region of residence and the level of protection
Number of women | Intention to screen response rate per 100 (%) with 95% CI | Mean age (95% CI) of responders | Intetion to screen histology outcome | ||||||
---|---|---|---|---|---|---|---|---|---|
HSIL/CIN2+ | HSIL/CIN3+ | ||||||||
no. | per 1000 (‰) with 95% CI | no. | per 1000 (‰) with 95% CI | ||||||
ALL WOMEN | All women | 26,556 | 33.8% (33.2%.34.4%) | 49.0 (48.7-49.2) | 94 | 3.5‰ (2.9‰–4.4‰) | 71 | 2.7‰ (2.1‰–3.4‰) | |
Responders | 8,972 | ||||||||
STUDY GROUPS | I1 opt-in | all | 14,400 | 34.0% (33.2%–34.8%) | 49.0 (48.7-49.3) | 49 | 3.4‰ (2.5‰–4.5‰) | 36 | 2.5‰ (1.8‰–3.5‰) |
responders | 4,896 | ||||||||
I2 opt-out | all | 9,556 | 37.7% (36.7%–38.6%) | 49.0 (48.6-49.3) | 37 | 3.9‰ (2.8‰–5.4‰) | 30 | 3.1‰ (2.2‰–4.5‰) | |
responders | 3,598 | ||||||||
P control | all | 2,600 | 18.4% (16.9%–19.9%) | 48.0 (47.2-48.9) | 8 | 3.1‰ (1.4‰–6.3‰) | 5 | 1.9‰ (0.7‰–4.8‰)) | |
responders | 478 | ||||||||
< 0.000 Statistically significant result at α = 0.05. | 0.766 | 0.557 | |||||||
REGION | Celje | all | 11,055 | 33.2% (32.3%–34.0%) | 48.3 (47.9-48.6) | 38 | 3.4‰ (2.5‰–4.8‰) | 28 | 2.5‰ (1.7‰–3.7‰) |
responders | 3,666 | ||||||||
Maribor | all | 15,501 | 34.2% (33.5%–35.0%) | 49.4 (49.2-49.7) | 56 | 3.6‰ (2.8‰–4.7‰) | 43 | 2.8‰ (2.0‰–3.8‰) | |
responders | 5,306 | ||||||||
0.070 | 0.813 | 0.708 | |||||||
LEVEL OF PROTECTION | Medium | all | 12,464 | 51.1% (50.2%–52.0%) | 48.4 (48.2-48.7) | 48 | 3.9‰ (2.9‰–5.1‰) | 33 | 2.6‰ (1.9‰–3.8‰) |
responders | 6,367 | ||||||||
No/low | all | 14,092 | 18.5% (17.8%–19.1%) | 51.1 (50.9-51.3) | 46 | 3.3‰ (2.4‰–4.4‰) | 38 | 2.7‰ (1.9‰–3.7‰) | |
responders | 2,605 | ||||||||
< 0.000 Statistically significant result at α = 0.05. | 0.422 | 0.838 |
Response rate stratified by the level of protection due to previous screening_ Intention-to-screen response rates are presented as absolute numbers, proportions (per 100) and 95% confidence intervals (CI) by the study group and the region of residence
Level of protection | |||||||
---|---|---|---|---|---|---|---|
Medium | No/low | ||||||
Number of women | Response rate per 100 (%) with 95% CI | Number of women | Response rate per 100 (%) with 95% CI | ||||
STUDY GROUPS | I1 opt-in | all | 6,796 | 51.5% (50.3%–52.7%) | 7,604 | 18.3% (17.5%–19.2%) | |
responders | 3,501 | 1,395 | |||||
I2 opt-out | all | 4,540 | 54.8% (53.3%–56.2%) | 5,016 | 22.2% (21.0%–23.3%) | ||
responders | 2,486 | 1,112 | |||||
P control | all | 1,128 | 33.7% (30.9%–36.5%) | 1,472 | 6.7% (5.5%–8.1%) | ||
responders | 380 | 98 | |||||
< 0.000 Statistically significant result at α = 0.05. | < 0.000 Statistically significant result at α = 0.05. | ||||||
REGION | Celje | all | 5,361 | 50.4% (49.0%–51.7%) | 5,694 | 17.0% (16.0%–18.0%) | |
responders | 2,700 | 966 | |||||
Maribor | all | 7,103 | 51.6% (50.5%–52.8%) | 8,398 | 19.5% (18.7%–20.4%) | ||
responders | 3,667 | 1,639 | |||||
0.163 | < 0.000 Statistically significant result at α = 0.05. |
Characteristics of women enrolled in the study
All randomly selected and allocated women | Total | STUDY GROUPS | ||||
---|---|---|---|---|---|---|
Number | I1 opt-in | I2 opt-out | P control | P-value | ||
Number | 26,556 | 100.0 | 14,400 | 9,556 | 2,600 | |
49.8 (49.7-50.0) | 49.8 (49.7-50.0) | 49.8 (49.6-50.0) | 50.0 (49.6-50.3) | |||
Mean age (95% CI) | ||||||
medium | 12,464 | 46.9 | 6,796 | 4,540 | 1,128 | Statistically significant result at α = 0.05. |
no/low | 14,092 | 53.1 | 7,604 | 5,016 | 1,472 | |
Celje | 11,055 | 41.6 | 5,996 | 3,984 | 1,075 | |
Maribor | 15,501 | 58.4 | 8,404 | 5,572 | 1,525 |